While Professor Ciechanover’s recent venture into the realm of cannabis is relatively new, he is no stranger to the vast landscape of pharmaceutical sciences. His years as a practising physician and consultant for various pharmaceutical organizations have endowed him with valuable insights and experiences. He believes these experiences will prove invaluable in navigating the multifaceted domain of cannabis.
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of…
Based on the ruling, products that are legal federally as well as at the state…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture —…
The new partnership will spotlight the stories of people still behind bars for cannabis, support…
Colombia is moving forward with a controversial plan to euthanize dozens of invasive hippos descended…
Imported hashish sustained mountain economies for centuries—until modern legalization and market economics erased it almost…